Vinati Organics LtdQ1 FY26Chemicals & Petrochemicals

Vinati Organics Ltd

Q1 FY26 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Revenue guidance

Category 3

→FY26 growth was similar to FY25, around 5%.
→Targeting approximately 15% volume growth at the company level in FY27.
→Antioxidants segment delivered 15% revenue growth in FY26 and expected to maintain strong momentum in FY27.
→ATBS expected to see 15% volume growth year-on-year for the next 3 years.
→Butyl phenols expect moderate growth in FY27.
→IB and HP-MTBE expected to achieve double-digit growth in FY27.
→IBB volumes declined in FY26 due to raw material unavailability but production and sales are now back on track.
→Customized products showed strong 10% year-on-year growth, expected to continue.
→Long-term growth planned via organic expansion with INR250-300 crores annual investment for 3-5 years.
→Revenue from new products including AO and butyl phenols expected to reach INR800-900 crores in next 2 years.

Category 3

→FY26 growth was modest at around 5% compared to FY25.
→Antioxidants segment expects continued strong momentum and market expansion, supporting growth.
→ATBS segment anticipates approximately 15% volume growth year-on-year for the next 3 years.
→Butyl phenols segment expects moderate growth supported by improving demand.
→IB and HP-MTBE products forecast double-digit growth in FY27.
→IBB production and sales have normalized after prior raw material challenges.
→Overall company targets approximately 15% volume growth in FY27.
→EBITDA margin guidance maintained at 26%-27% for the long term.
→Capex of INR 200-250 crores planned for FY27 focused on capacity expansion and new product introductions.
→VOPL subsidiary expected to contribute revenues (~INR100-120 crores) starting Q3 FY27 after process reengineering.
→Company remains debt-free and funded through internal accruals, indicating strong financial health supporting growth.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Vinati Organics Ltd and 1,400+ other companies.

→Vinati Saraf Mutreja stated the company is focusing on organic expansion with a pipeline of products and plans to invest INR250-300 crores annually for the next 3 to 5 years.
→The company has been achieving all expansion goals through internal accruals and remains debt-free.
→There is no mention of plans for raising new funds through equity or debt in the transcript.
→The management confirmed that they will continue the policy of no debt going forward.
→The company has a treasury of approximately INR190 crores as of March 31, 2026, supporting their financial stability without external financing.

→No explicit mention of a current or expected order book or pending orders was made in the transcript.
→For ATBS, capacity utilization is about 75-80%, indicating healthy demand, but no specific backlog figures were shared.
→Management indicated stable industry growth with expectations of approximately 15% volume growth in FY27.
→No direct references to order backlog numbers or pending orders were given during the Q&A.
→The company is focusing on organic expansion with planned capex of INR250-300 crores annually for product development and capacity enhancement.
→Process reengineering for certain products in the subsidiary VOPL is expected to end by September, with revenue starting from Q3 FY27.
→Management highlighted stable raw material availability and logistics, supporting uninterrupted fulfillment of orders.

Yes

→FY26 capex was approximately INR 270 crores, including investments in VOPL for capacity expansion, new product development, and operational scalability.
→FY27 capex is earmarked at around INR 200-250 crores focusing on capacity expansion, innovation, and operational efficiency.
→Major portion (~INR 200 crores) of FY27 capex will be through the main holding company Vinati Organics Limited; INR 40-50 crores through subsidiary VOPL.
→The ATBS capacity expansion completed, with further utilization expected from FY28 onwards.
→Process reengineering at VOPL expected to be completed by September 2026; revenue contribution from Q3 FY27.
→New products under R&D targeting niche chemicals for industries such as food additives, fragrance, personal care, antioxidants, and plastics.
→Investment plans continue to be financed through internal accruals; the company remains debt-free with treasury of ~INR 190 crores as of March 31, 2026.

How does Vinati Organics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Vinati Organics Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Vinati Organics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.